Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There are a growing number of adolescents with chronic medical conditions in the United States. The Advisory Committee on Immunization Practices (ACIP) recommends HPV vaccination and annual influenza vaccination of all adolescents. Pneumococcal polysaccharide vaccination is also recommended for certain high-risk patients. Limited studies suggest that vaccination coverage of this population remains sub-optimal. Text message vaccine reminder/recall has been shown to be effective in increasing uptake of select pediatric and adolescents vaccines, but has yet to be examined among patients with chronic medical conditions who may also face unique barriers to vaccination. This intervention aims to implement and evaluate the use of text message vaccine reminders among urban low-income minority adolescents with chronic medical conditions. This investigator-initiated study is supported in part by a grant from the Pfizer Medical Education Group.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| educational text message reminders | Experimental | receipt of education-embedded text message vaccine reminders |
|
| conventional text message reminders | Active Comparator | receipt of conventional text message vaccine reminders |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| educational text message reminders | Other |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s) | 12 weeks after intervention start |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s) | 4 weeks after intervention start | |
| Percentage of eligible subjects who received HPV1, influenza, and/or pneumococcal vaccine(s) | 24 weeks after intervention start |
Not provided
Inclusion Criteria:
Parent with
Exclusion Criteria:
Parent who:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Annika M Hofstetter, MD, PhD, MPH | Columbia University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| NewYork-Presbyterian Hospital/Columbia University Medical Center | New York | New York | 10032 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28736201 | Derived | Hofstetter AM, Barrett A, Camargo S, Rosenthal SL, Stockwell MS. Text message reminders for vaccination of adolescents with chronic medical conditions: A randomized clinical trial. Vaccine. 2017 Aug 16;35(35 Pt B):4554-4560. doi: 10.1016/j.vaccine.2017.07.022. Epub 2017 Jul 21. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| conventional text message reminders | Other |
|
|
| Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination | 4 weeks after intervention start |
| Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination | 12 weeks after intervention start |
| Percentage of eligible subjects with missed opportunities for HPV1, influenza, and/or pneumococcal vaccination | 24 weeks after intervention start |